Buy
1
Hold
0
Sell
0
Watch
0
Presenter highlights MYO as the most established company on the list, with Q1 2026 revenue of $10.1M, gross margins above 68%, a healthy cash position of $15.7M, and full-year revenue guidance of $43-46M. The Myopro robotic arm brace uses AI-powered myoelectric sensors to help patients with paralysis regain movement. A company director recently purchased ~$174K in stock, signaling insider confidence. Though slightly above $1 at $1.10, it's still considered penny stock territory.